» Articles » PMID: 25224616

The Importance of Choice in the Rollout of ARV-based Prevention to User Groups in Kenya and South Africa: a Qualitative Study

Overview
Journal J Int AIDS Soc
Date 2014 Sep 17
PMID 25224616
Citations 50
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Stakeholders continue to discuss the appropriateness of antiretroviral-based pre-exposure prophylaxis (PrEP) for HIV prevention among sub-Saharan African and other women. In particular, women need formulations they can adhere to given that effectiveness has been found to correlate with adherence. Evidence from family planning shows that contraceptive use, continuation and adherence may be increased by expanding choices. To explore the potential role of choice in women's use of HIV prevention methods, we conducted a secondary analysis of research with female sex workers (FSWs) and men and women in serodiscordant couples (SDCs) in Kenya, and adolescent and young women in South Africa. Our objective here is to present their interest in and preferences for PrEP formulations - pills, gel and injectable.

Methods: In this qualitative study, in Kenya we conducted three focus groups with FSWs, and three with SDCs. In South Africa, we conducted two focus groups with adolescent girls, and two with young women. All focus groups were audio-recorded, transcribed and translated into English as needed. We structurally and thematically coded transcripts using a codebook and QSR NVivo 9.0; generated code reports; and conducted inductive thematic analysis to identify major trends and themes.

Results: All groups expressed strong interest in PrEP products. In Kenya, FSWs said the products might help them earn more money, because they would feel safer accepting more clients or having sex without condoms for a higher price. SDCs said the products might replace condoms and reanimate couples' sex lives. Most sex workers and SDCs preferred an injectable because it would last longer, required little intervention and was private. In South Africa, adolescent girls believed it would be possible to obtain the products more privately than condoms. Young women were excited about PrEP but concerned about interactions with alcohol and drug use, which often precede sex. Adolescents did not prefer a particular formulation but noted benefits and limitations of each; young women's preferences also varied.

Conclusions: The circumstances and preferences of sub-Saharan African women are likely to vary within and across groups and to change over time, highlighting the importance of choice in HIV prevention methods.

Citing Articles

Qualitative focus group discussions exploring PrEP method and service delivery preferences among female sex workers and their managers in four Zambian provinces.

Evens E, Munthali T, Mangunje F, Kotaka M, Burke H, Musonda B BMJ Public Health. 2025; 2(1):e000483.

PMID: 40018231 PMC: 11816290. DOI: 10.1136/bmjph-2023-000483.


Cost thresholds for anticipated long-acting HIV pre-exposure prophylaxis products in Eastern and Southern Africa: a mathematical modelling study.

Kaftan D, Sharma M, Resar D, Milali M, Mudimu E, Wu L J Int AIDS Soc. 2025; 28(2):e26427.

PMID: 39995017 PMC: 11850439. DOI: 10.1002/jia2.26427.


Willingness to Use Long-Acting Injectable Pre-Exposure Prophylaxis among Adolescent Girls and Young Women in Kampala, Uganda.

Lunkuse J, Lwanga C, Wamono F, Muturi-Kioi V, Price M, Mayanja Y AIDS Behav. 2025; .

PMID: 39883369 DOI: 10.1007/s10461-025-04616-y.


Barriers to PrEP use and adherence among adolescent girls and young women in Eastern, Southern, and Western Africa: a scoping review.

Admassu M, Nostlinger C, Hensen B BMC Womens Health. 2024; 24(1):665.

PMID: 39725977 PMC: 11670510. DOI: 10.1186/s12905-024-03516-y.


The effect of daily oral PrEP use during pregnancy on bone mineral density among adolescent girls and young women in Uganda.

Zewdie K, Kiweewa F, Ssebuliba T, Morrison S, Muwonge T, Boyer J Front Reprod Health. 2024; 5:1240990.

PMID: 38260049 PMC: 10801233. DOI: 10.3389/frph.2023.1240990.


References
1.
Liu A, Kittredge P, Vittinghoff E, Raymond H, Ahrens K, Matheson T . Limited knowledge and use of HIV post- and pre-exposure prophylaxis among gay and bisexual men. J Acquir Immune Defic Syndr. 2008; 47(2):241-7. View

2.
Nodin N, Carballo-Dieguez A, Ventuneac A, Balan I, Remien R . Knowledge and acceptability of alternative HIV prevention bio-medical products among MSM who bareback. AIDS Care. 2008; 20(1):106-15. DOI: 10.1080/09540120701449096. View

3.
Person A, Hicks C . Pre-exposure prophylaxis--one more tool for HIV prevention. Curr HIV Res. 2012; 10(2):117-22. DOI: 10.2174/157016212799937254. View

4.
Terris-Prestholt F, Hanson K, MacPhail C, Vickerman P, Rees H, Watts C . How much demand for New HIV prevention technologies can we really expect? Results from a discrete choice experiment in South Africa. PLoS One. 2014; 8(12):e83193. PMC: 3875434. DOI: 10.1371/journal.pone.0083193. View

5.
Heffron R, Ngure K, Mugo N, Celum C, Kurth A, Curran K . Willingness of Kenyan HIV-1 serodiscordant couples to use antiretroviral-based HIV-1 prevention strategies. J Acquir Immune Defic Syndr. 2012; 61(1):116-9. PMC: 3427394. DOI: 10.1097/QAI.0b013e31825da73f. View